Full notification file
General informationNotification NumberB/GB/02/37/02Member State to which the notification was sentUnited KingdomDate of acknowledgement from the Member State Competent Authority19/12/2002Title of the ProjectAn open-label study to determine the safety and immunogenicity of two dose levels (10E8 or 10E9 CFU) of a candidate oral immunotherapy (Hep B Candidate 1) against hepatitis B, given on two occasions, 56 days apart to healthy subjectsProposed period of release:01/04/2003 to 30/06/2004Name of the Institute(s) or Company(ies)Microscience Ltd., ;
3. Is the same GMO release planned elsewhere in the Community?NoHas the same GMPt been notified elsewhere by the same notifier?NoGMO characterizationGMO is a:BacteriumIdentity of the GMO:Enterobacteriaceae: Salmonella entericaInformation relating to the recipient or parental organisms from wich the GMO is derived| Common Name | Genus | Species | Subspecies | Strain | Pathovar | | Attenuated S. typhi Ty2 | Enterobacteriaceae | Salmonella enterica | serovar Typhi | Ty2 | Not known |
|
European Commission administrative informationConsent given by the Member State Competent Authority:Not known